SYSTEM OF ANALYZING COMPLEX MIXTURES OF BIOLOGICAL AND OTHERFLUIDS TO IDENTIFY BIOLOGICAL STATE INFORMATION

摘要

A business method for use in classifying patient samples. The method include s steps of collecting case samples representing a clinical phenotypic state and control samples representing patients without said clinical phenotypic state. Preferably the system uses a mass spectrometry platform system to identify patterns of polypeptides in sa id case samples and in the control samples without regard to the specific identity of at lea st some of said polypeptides. Based on identified representative patterns of the state, the system performs optimized assays for greater sensitivity, specificity, and/or cost effectiveness and the business method provides for the marketing of diagnostic products using representativ e patterns.